Summary: Researchers report a major advance in autism research: structural brain abnormalities and related behavioral deficits in a mouse model of autism spectrum disorder (ASD) were reversed. The team identified a clear defect in the axon initial segment (AIS) — the critical segment at the root of a neuron where electrical action potentials originate — and used a targeted chemogenetic approach to restore normal AIS structure and behavior.
Using a circuit-specific chemogenetic method in a validated ASD mouse model, investigators succeeded in restoring shortened AIS lengths to normal values. This structural recovery was accompanied by restored social behavior and a pronounced reduction in repetitive behaviors commonly used to model autism-like traits in mice.
Key Facts
- AIS structural defect: The axon initial segment (AIS) was found to be abnormally shortened in affected neurons. Because the AIS is the site where action potentials begin, its altered structure reduces a neuron’s ability to fire reliably.
- Critical social circuit affected: The defect was observed in projection neurons connecting the medial prefrontal cortex (a brain region central to social cognition) to the dorsal raphe nucleus, a pathway important for social behavior regulation.
- Relevant genetic model: Findings were obtained in 15q duplication (15q dup) mice, a laboratory model that carries the same chromosomal duplication linked to human ASD.
- Circuit-specific chemogenetic activation: The team used DREADD (designer receptors exclusively activated by designer drugs) to selectively stimulate the prefrontal-to-dorsal raphe projection neurons and test whether AIS changes could be reversed.
- Structural and behavioral rescue: Targeted activation normalized AIS length and neuronal excitability in the affected circuit and produced measurable improvements in social interactions and reductions in repetitive behaviors in the mice.
- Therapeutic implication: Led by Professor Masashi Fujitani and Assistant Professor Yoshinori Otani, the study shows that AIS alterations in this ASD model reflect reversible maladaptive plasticity rather than permanent neuronal damage, suggesting a new circuit-based foundation for potential therapies.
Source: Shimane University
Overview: Autism spectrum disorder (ASD) is a neurodevelopmental condition that typically appears in early childhood. While genetics and atypical brain development are known contributors, there is no definitive cure. Identifying reversible neural changes and circuit-specific interventions is a central challenge for neuroscience and clinical translation.
A multidisciplinary team from Shimane University (Department of Anatomy and Neuroscience), Kobe University and Hyogo Medical University analyzed 15q dup mice and documented prominent AIS abnormalities. Their findings were published in Cell Death & Disease on May 19, 2026.
The researchers observed that pyramidal neurons in the medial prefrontal cortex (mPFC) exhibited a shortened AIS, which led to decreased neuronal excitability and compromised plasticity. These deficits were especially pronounced in long-range projection neurons forming the mPFC-to-dorsal raphe nucleus (DRN) pathway—a circuit implicated in social behavior.
To determine whether these structural and functional changes could be reversed, the investigators applied a chemogenetic DREADD strategy to selectively increase activity in mPFC–DRN projection neurons. This circuit-targeted activation restored AIS length to normal and rescued key behavioral measures: social interaction improved and repetitive behaviors were substantially reduced.
According to Professor Masashi Fujitani, these results indicate that AIS deficits in this ASD model are not fixed lesions but a form of maladaptive plasticity that can be reversed by appropriately timed, circuit-specific interventions. The study provides direct evidence linking structural AIS recovery with behavioral improvement.
Key Questions Answered:
A: The axon initial segment (AIS) is the portion of a neuron where action potentials are generated and where the cell’s excitability is regulated. In the studied ASD model, the AIS is abnormally short in specific social-circuit neurons, limiting their ability to fire and communicate effectively, which likely contributes to behavioral deficits.
A: Researchers used DREADD, a chemogenetic technique that allows selective activation of targeted neural projections. Repeated, selective activation of the prefrontal-to-dorsal raphe pathway promoted AIS elongation back to normal lengths and restored neuronal excitability.
A: The findings support the idea that specific neural circuit dysfunctions in ASD may be reversible. Demonstrating that targeted circuit modulation can rebuild neuronal structure and rescue behavior opens a promising path for developing circuit-targeted therapies, although translation to humans will require extensive further research.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal article was reviewed in full by the editorial team.
- Additional explanatory context was provided by staff to clarify findings and implications.
About this autism research news
Author: Shuko Imawaka
Source: Shimane University
Contact: Shuko Imawaka – Shimane University
Image: The image is credited to Neuroscience News
Original Research: Open access. Restoration of axon initial segment plasticity via chemogenetic activation rescues autism-related behaviors by Yoshinori Otani et al., Cell Death and Disease. DOI: 10.1038/s41419-026-08873-0
Abstract
Restoration of axon initial segment plasticity via chemogenetic activation rescues autism-related behaviors
Autism spectrum disorder (ASD) presents a major clinical challenge, motivating the search for therapeutic targets grounded in its underlying neurobiology. The axon initial segment (AIS) is the primary site for initiating action potentials and a locus for homeostatic plasticity, but its role in ASD has been unclear.
In this study, researchers report significant structural and functional deficits of the AIS in a clinically relevant ASD mouse model carrying a 15q11–13 duplication (15q dup). Pyramidal neurons in the medial prefrontal cortex showed shortened AIS, reduced excitability and impaired plasticity. These changes were particularly associated with long-range mPFC–dorsal raphe nucleus projections that support social behavior.
Using a circuit-specific chemogenetic approach to activate these projection neurons, the investigators demonstrated that AIS structure could be normalized and that core ASD-like behaviors—reduced social interaction and increased repetitive behaviors—could be rescued. These observations indicate that AIS alterations in this model represent reversible maladaptive plasticity rather than permanent neuropathology.
The study highlights circuit-specific modulation of AIS plasticity as a promising strategy for developing novel interventions aimed at correcting neuronal excitability deficits in ASD.